Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-25-003498
Filing Date
2025-05-09
Accepted
2025-05-09 16:45:24
Documents
46
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q celz_10q.htm   iXBRL 10-Q 453605
2 CERTIFICATION celz_ex311.htm EX-31.1 10750
3 CERTIFICATION celz_ex312.htm EX-31.2 10623
4 CERTIFICATION celz_ex321.htm EX-32.1 5231
5 CERTIFICATION celz_ex322.htm EX-32.2 4368
11 celz_10qimg2.jpg GRAPHIC 49774
  Complete submission text file 0001477932-25-003498.txt   2726689

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA celz-20250331.xsd EX-101.SCH 29447
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE celz-20250331_lab.xml EX-101.LAB 189754
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celz-20250331_cal.xml EX-101.CAL 29081
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celz-20250331_pre.xml EX-101.PRE 154811
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celz-20250331_def.xml EX-101.DEF 82857
49 EXTRACTED XBRL INSTANCE DOCUMENT celz_10q_htm.xml XML 256878
Mailing Address 211 E. OSBORN RD. PHOENIX AZ 85012
Business Address 211 E. OSBORN RD. PHOENIX AZ 85012 480-399-2822
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001187953 (see all company filings)

EIN.: 870622284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41120 | Film No.: 25931203
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)